Alexandre Buckmelter

Person

Superior, CO, US

People

Patents Grantslast 30 patents

Information Patent Grant
Fused bicyclic compounds useful as ubiquitin-specific peptidase 30...
- Patent number 12,049,466
- Issue date Jul 30, 2024
- Forma Therapeutics, Inc.
- Matthew W. Martin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Purinones as ubiquitin-specific protease 1 inhibitors
- Patent number 12,043,623
- Issue date Jul 23, 2024
- Forma Therapeutics, Inc.
- Alexandre Joseph Buckmelter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 in...
- Patent number 12,018,030
- Issue date Jun 25, 2024
- Valo Health, Inc.
- Stephanos Ioannidis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific pro...
- Patent number 11,795,171
- Issue date Oct 24, 2023
- Valo Health, Inc.
- Stephanos Ioannidis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinazolinones and azaquinazolinones as ubiquitin-specific protease...
- Patent number 11,739,071
- Issue date Aug 29, 2023
- Valo Health, Inc.
- Stephanos Ioannidis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and compositions for the inhibition of NAMPT
- Patent number 11,547,701
- Issue date Jan 10, 2023
- Valo Health, Inc.
- Kenneth W. Bair
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Piperidine derivatives and compositions for the inhibition of nicot...
- Patent number 11,479,564
- Issue date Oct 25, 2022
- Valo Health, Inc.
- Kenneth W. Bair
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and compositions for the inhibition of NAMPT
- Patent number 11,279,687
- Issue date Mar 22, 2022
- Valo Health, Inc.
- Kenneth W. Bair
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibiting ubiquitin specific peptidase 30
- Patent number 11,247,987
- Issue date Feb 15, 2022
- Forma Therapeutics, Inc.
- Justin Caravella
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinazoline analogs as receptor tyrosine kinase inhibitors
- Patent number 11,174,273
- Issue date Nov 16, 2021
- Array Biopharma Inc.
- Eli Wallace
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Purinones as ubiquitin-specific protease 1 inhibitors
- Patent number 11,161,848
- Issue date Nov 2, 2021
- Forma Therapeutics, Inc.
- Alexandre Joseph Buckmelter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific pro...
- Patent number 10,981,915
- Issue date Apr 20, 2021
- Valo Early Discovery, Inc.
- Stephanos Ioannidis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 in...
- Patent number 10,934,299
- Issue date Mar 2, 2021
- Valo Early Discovery, Inc.
- Stephanos Ioannidis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimid...
- Patent number 10,927,130
- Issue date Feb 23, 2021
- Valo Early Discovery, Inc.
- Stephanos Ioannidis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors
- Patent number 10,906,916
- Issue date Feb 2, 2021
- Valo Early Discovery, Inc.
- Stephanos Ioannidis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Quinazolinones and azaquinazolinones as ubiquitin-specific protease...
- Patent number 10,836,741
- Issue date Nov 17, 2020
- Valo Early Discovery, Inc.
- Stephanos Ioannidis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and compositions for the inhibition of NAMPT
- Patent number 10,772,874
- Issue date Sep 15, 2020
- Kenneth W. Bair
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Amido-benzyl sulfone and sulfoxide derivates
- Patent number 10,696,692
- Issue date Jun 30, 2020
- Kenneth W Bair
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and compositions for the inhibition of NAMPT
- Patent number 10,647,695
- Issue date May 12, 2020
- Forma TM, LLC
- Kenneth W. Bair
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinazolinones and azaquinazolinones as ubiquitin-specific protease...
- Patent number 10,519,127
- Issue date Dec 31, 2019
- Forma Therapeutics, Inc.
- Stephanos Ioannidis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinazolinones and azaquinazolinones as ubiquitin-specific protease...
- Patent number 10,519,129
- Issue date Dec 31, 2019
- Forma Therapeutics, Inc.
- Stephanos Ioannidis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinazolinones and azaquinazolinones as ubiquitin-specific protease...
- Patent number 10,519,130
- Issue date Dec 31, 2019
- Forma Therapeutics, Inc.
- Stephanos Ioannidis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinazolinones and azaquinazolinones as ubiquitin-specific protease...
- Patent number 10,519,128
- Issue date Dec 31, 2019
- Forma Therapeutics, Inc.
- Stephanos Ioannidis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinazolinones and azaquinazolinones as ubiquitin-specific protease...
- Patent number 10,513,508
- Issue date Dec 24, 2019
- Forma Therapeutics, Inc.
- Stephanos Ioannidis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinazolinones and azaquinazolinones as ubiquitin-specific protease...
- Patent number 10,513,507
- Issue date Dec 24, 2019
- Forma Therapeutics, Inc.
- Stephanos Ioannidis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinazolinones and azaquinazolinones as ubiquitin-specific protease...
- Patent number 10,508,098
- Issue date Dec 17, 2019
- Forma Therapeutics, Inc.
- Stephanos Ioannidis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and compositions for the inhibition of NAMPT
- Patent number 10,456,382
- Issue date Oct 29, 2019
- Forma TM, LLC
- Kenneth W. Bair
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Purinones as ubiquitin-specific protease 1 inhibitors
- Patent number 10,399,980
- Issue date Sep 3, 2019
- Forma Therapeutics, Inc.
- Alexandre Joseph Buckmelter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimid...
- Patent number 10,377,773
- Issue date Aug 13, 2019
- Forma Therapeutics, Inc.
- Stephanos Ioannidis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 in...
- Patent number 10,377,760
- Issue date Aug 13, 2019
- Forma Therapeutics, Inc.
- Stephanos Ioannidis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
INHIBITING UBIQUITIN-SPECIFIC PROTEASE 1 (USP1)
- Publication number 20240239808
- Publication date Jul 18, 2024
- Forma Therapeutics, Inc.
- Loren Berry
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT
- Publication number 20230346753
- Publication date Nov 2, 2023
- Valo Health, Inc.
- Kenneth W. Bair
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PIPERIDINE DERIVATIVES AND COMPOSITIONS FOR THE INHIBITION OF NICOT...
- Publication number 20230110003
- Publication date Apr 13, 2023
- Valo Health, Inc.
- Kenneth W. Bair
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PURINONES AS UBIQUITIN-SPECIFIC PROTEASE 1 INHIBITORS
- Publication number 20220281869
- Publication date Sep 8, 2022
- Forma Therapeutics, Inc.
- Alexandre Joseph Buckmelter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITING UBIQUITIN SPECIFIC PEPTIDASE 30
- Publication number 20220185806
- Publication date Jun 16, 2022
- Forma Therapeutics, Inc.
- Justin Caravella
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS FOR INHIBITING UBIQUITIN SPECIFIC PROTEASE 1
- Publication number 20220073525
- Publication date Mar 10, 2022
- Forma Therapeutics, Inc.
- Alexandre Joseph Buckmelter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRROLOTRIAZINONES AND IMIDAZOTRIAZINONES AS UBIQUITIN-SPECIFIC PRO...
- Publication number 20220033403
- Publication date Feb 3, 2022
- Valo Health, Inc.
- Stephanos Ioannidis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRROLO AND PYRAZOLOPYRIMIDINES AS UBIQUITIN-SPECIFIC PROTEASE 7 IN...
- Publication number 20210332052
- Publication date Oct 28, 2021
- Valo Early Discovery, Inc.
- Stephanos Ioannidis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THIENOPYRIMIDINONES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS
- Publication number 20210292337
- Publication date Sep 23, 2021
- Valo Early Discovery, Inc.
- Stephanos Ioannidis
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Application
QUINAZOLINE ANALOGS AS RECEPTOR TYROSINE KINASE INHIBITORS
- Publication number 20210284656
- Publication date Sep 16, 2021
- ARRAY BIOPHARMA INC.
- Eli Wallace
- C04 - CEMENTS CONCRETE ARTIFICIAL STONE CERAMICS REFRACTORIES
Information Patent Application
QUINAZOLINE ANALOGS AS RECEPTOR TYROSINE KINASE INHIBITORS
- Publication number 20210269455
- Publication date Sep 2, 2021
- ARRAY BIOPHARMA INC.
- Eli Wallace
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT
- Publication number 20210244717
- Publication date Aug 12, 2021
- Valo Early Discovery, Inc.
- Kenneth W. Bair
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PIPERIDINE DERIVATIVES AND COMPOSITIONS FOR THE INHIBITION OF NICOT...
- Publication number 20210246147
- Publication date Aug 12, 2021
- Valo Early Discovery, Inc.
- Kenneth W. Bair
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED BICYCLIC COMPOUNDS USEFUL AS UBIQUITIN-SPECIFIC PEPTIDASE 30...
- Publication number 20210198263
- Publication date Jul 1, 2021
- Forma Therapeutics, Inc.
- Matthew W. MARTIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
QUINAZOLINONES AND AZAQUINAZOLINONES AS UBIQUITIN-SPECIFIC PROTEASE...
- Publication number 20210130321
- Publication date May 6, 2021
- Valo Early Discovery, Inc.
- Stephanos Ioannidis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITING UBIQUITIN SPECIFIC PEPTIDASE 30
- Publication number 20200317658
- Publication date Oct 8, 2020
- Forma Therapeutics, Inc.
- Justin Caravella
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT
- Publication number 20200283403
- Publication date Sep 10, 2020
- FORMA TM, LLC
- Kenneth W. Bair
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
QUINAZOLINONES AND AZAQUINAZOLINONES AS UBIQUITIN-SPECIFIC PROTEASE...
- Publication number 20200087280
- Publication date Mar 19, 2020
- Forma Therapeutics, Inc.
- Stephanos Ioannidis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PURINONES AS UBIQUITIN-SPECIFIC PROTEASE 1 INHIBITORS
- Publication number 20200079776
- Publication date Mar 12, 2020
- Forma Therapeutics, Inc.
- Alexandre Joseph Buckmelter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT
- Publication number 20190388405
- Publication date Dec 26, 2019
- FORMA TM, LLC
- Kenneth W. Bair
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRROLO AND PYRAZOLOPYRIMIDINES AS UBIQUITIN-SPECIFIC PROTEASE 7 IN...
- Publication number 20190367525
- Publication date Dec 5, 2019
- Forma Therapeutics, Inc.
- Stephanos Ioannidis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THIENOPYRIMIDINONES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS
- Publication number 20190359629
- Publication date Nov 28, 2019
- FORMA Therapeutics, Inc.
- Stephanos Ioannidis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ISOTHIAZOLOPYRIMIDINONES, PYRAZOLOPYRIMIDINONES, AND PYRROLOPYRIMID...
- Publication number 20190359635
- Publication date Nov 28, 2019
- Forma Therapeutics, Inc.
- Stephanos Ioannidis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRROLOTRIAZINONES AND IMIDAZOTRIAZINONES AS UBIQUITIN-SPECIFIC PRO...
- Publication number 20190308980
- Publication date Oct 10, 2019
- Forma Therapeutics, Inc.
- Stephanos Ioannidis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT
- Publication number 20190270721
- Publication date Sep 5, 2019
- FORMA TM, LLC
- Kenneth W. Bair
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
QUINAZOLINE ANALOGS AS RECEPTOR TYROSINE KINASE INHIBITORS
- Publication number 20190161500
- Publication date May 30, 2019
- ARRAY BIOPHARMA INC.
- Eli Wallace
- C04 - CEMENTS CONCRETE ARTIFICIAL STONE CERAMICS REFRACTORIES
Information Patent Application
NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT
- Publication number 20190105307
- Publication date Apr 11, 2019
- FORMA TM, LLC
- Kenneth W. Bair
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
QUINAZOLINONES AND AZAQUINAZOLINONES AS UBIQUITIN-SPECIFIC PROTEASE...
- Publication number 20190071418
- Publication date Mar 7, 2019
- Forma Therapeutics, Inc.
- Stephanos Ioannidis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
QUINAZOLINONES AND AZAQUINAZOLINONES AS UBIQUITIN-SPECIFIC PROTEASE...
- Publication number 20190071420
- Publication date Mar 7, 2019
- Forma Therapeutics, Inc.
- Stephanos Ioannidis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
QUINAZOLINONES AND AZAQUINAZOLINONES AS UBIQUITIN-SPECIFIC PROTEASE...
- Publication number 20190071422
- Publication date Mar 7, 2019
- Forma Therapeutics, Inc.
- Stephanos Ioannidis
- C07 - ORGANIC CHEMISTRY

Alexandre Buckmelter

Person

Patents Grantslast 30 patents

Fused bicyclic compounds useful as ubiquitin-specific peptidase 30...

Purinones as ubiquitin-specific protease 1 inhibitors

Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 in...

Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific pro...

Quinazolinones and azaquinazolinones as ubiquitin-specific protease...

Compounds and compositions for the inhibition of NAMPT

Piperidine derivatives and compositions for the inhibition of nicot...

Compounds and compositions for the inhibition of NAMPT

Inhibiting ubiquitin specific peptidase 30

Quinazoline analogs as receptor tyrosine kinase inhibitors

Purinones as ubiquitin-specific protease 1 inhibitors

Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific pro...

Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 in...

Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimid...

Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors

Quinazolinones and azaquinazolinones as ubiquitin-specific protease...

Compounds and compositions for the inhibition of NAMPT

Amido-benzyl sulfone and sulfoxide derivates

Compounds and compositions for the inhibition of NAMPT

Quinazolinones and azaquinazolinones as ubiquitin-specific protease...

Quinazolinones and azaquinazolinones as ubiquitin-specific protease...

Quinazolinones and azaquinazolinones as ubiquitin-specific protease...

Quinazolinones and azaquinazolinones as ubiquitin-specific protease...

Quinazolinones and azaquinazolinones as ubiquitin-specific protease...

Quinazolinones and azaquinazolinones as ubiquitin-specific protease...

Quinazolinones and azaquinazolinones as ubiquitin-specific protease...

Compounds and compositions for the inhibition of NAMPT

Purinones as ubiquitin-specific protease 1 inhibitors

Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimid...

Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 in...

Patents Applicationslast 30 patents

INHIBITING UBIQUITIN-SPECIFIC PROTEASE 1 (USP1)

NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT

PIPERIDINE DERIVATIVES AND COMPOSITIONS FOR THE INHIBITION OF NICOT...

PURINONES AS UBIQUITIN-SPECIFIC PROTEASE 1 INHIBITORS

INHIBITING UBIQUITIN SPECIFIC PEPTIDASE 30

COMPOSITIONS FOR INHIBITING UBIQUITIN SPECIFIC PROTEASE 1

PYRROLOTRIAZINONES AND IMIDAZOTRIAZINONES AS UBIQUITIN-SPECIFIC PRO...

PYRROLO AND PYRAZOLOPYRIMIDINES AS UBIQUITIN-SPECIFIC PROTEASE 7 IN...

THIENOPYRIMIDINONES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS

QUINAZOLINE ANALOGS AS RECEPTOR TYROSINE KINASE INHIBITORS

QUINAZOLINE ANALOGS AS RECEPTOR TYROSINE KINASE INHIBITORS

NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT

PIPERIDINE DERIVATIVES AND COMPOSITIONS FOR THE INHIBITION OF NICOT...

FUSED BICYCLIC COMPOUNDS USEFUL AS UBIQUITIN-SPECIFIC PEPTIDASE 30...

QUINAZOLINONES AND AZAQUINAZOLINONES AS UBIQUITIN-SPECIFIC PROTEASE...

INHIBITING UBIQUITIN SPECIFIC PEPTIDASE 30

NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT

QUINAZOLINONES AND AZAQUINAZOLINONES AS UBIQUITIN-SPECIFIC PROTEASE...

PURINONES AS UBIQUITIN-SPECIFIC PROTEASE 1 INHIBITORS

NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT

PYRROLO AND PYRAZOLOPYRIMIDINES AS UBIQUITIN-SPECIFIC PROTEASE 7 IN...

THIENOPYRIMIDINONES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS

ISOTHIAZOLOPYRIMIDINONES, PYRAZOLOPYRIMIDINONES, AND PYRROLOPYRIMID...

PYRROLOTRIAZINONES AND IMIDAZOTRIAZINONES AS UBIQUITIN-SPECIFIC PRO...

NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT

QUINAZOLINE ANALOGS AS RECEPTOR TYROSINE KINASE INHIBITORS

NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT

QUINAZOLINONES AND AZAQUINAZOLINONES AS UBIQUITIN-SPECIFIC PROTEASE...

QUINAZOLINONES AND AZAQUINAZOLINONES AS UBIQUITIN-SPECIFIC PROTEASE...

QUINAZOLINONES AND AZAQUINAZOLINONES AS UBIQUITIN-SPECIFIC PROTEASE...